GR3029685T3 - Retinoic acid-containing compositions. - Google Patents
Retinoic acid-containing compositions.Info
- Publication number
- GR3029685T3 GR3029685T3 GR990400769T GR990400769T GR3029685T3 GR 3029685 T3 GR3029685 T3 GR 3029685T3 GR 990400769 T GR990400769 T GR 990400769T GR 990400769 T GR990400769 T GR 990400769T GR 3029685 T3 GR3029685 T3 GR 3029685T3
- Authority
- GR
- Greece
- Prior art keywords
- retinoic acid
- urethane compound
- compositions
- skin
- approximately
- Prior art date
Links
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 title abstract 6
- 229930002330 retinoic acid Natural products 0.000 title abstract 6
- 229960001727 tretinoin Drugs 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- -1 urethane compound Chemical class 0.000 abstract 3
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 208000001126 Keratosis Diseases 0.000 abstract 1
- 206010051246 Photodermatosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 125000005442 diisocyanate group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 230000008845 photoaging Effects 0.000 abstract 1
- 229920001515 polyalkylene glycol Polymers 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/875,772 US5650171A (en) | 1992-04-29 | 1992-04-29 | Retinoic acid-containing polyether-polyurethane compositions |
| PCT/US1993/003540 WO1993021904A1 (en) | 1992-04-29 | 1993-04-20 | Retinoic acid-containing compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3029685T3 true GR3029685T3 (en) | 1999-06-30 |
Family
ID=25366337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990400769T GR3029685T3 (en) | 1992-04-29 | 1999-03-12 | Retinoic acid-containing compositions. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5650171A (el) |
| EP (1) | EP0670714B1 (el) |
| JP (1) | JPH07506109A (el) |
| AT (1) | ATE174505T1 (el) |
| AU (1) | AU679678B2 (el) |
| CA (1) | CA2134677C (el) |
| DE (1) | DE69322656T2 (el) |
| DK (1) | DK0670714T3 (el) |
| ES (1) | ES2127818T3 (el) |
| GR (1) | GR3029685T3 (el) |
| NZ (1) | NZ251858A (el) |
| WO (1) | WO1993021904A1 (el) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807957A (en) * | 1996-12-23 | 1998-09-15 | Macrochem Corporation | Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
| US6017549A (en) * | 1997-09-30 | 2000-01-25 | E-L Management Corp. | Non-irritating cosmetic and pharmaceutical compositions |
| US6277364B1 (en) | 1998-10-09 | 2001-08-21 | Bertek Pharmaceuticals, Inc. | Polyurethanes as topical skin protectants |
| US6270781B1 (en) | 1999-01-08 | 2001-08-07 | Maxim Pharmaceuticals, Inc. | Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| US6315991B1 (en) | 1999-03-24 | 2001-11-13 | Fleet Bank, National Association | Urethane surfactants and their use in personal care formulations |
| EP1145709A1 (de) * | 2000-04-14 | 2001-10-17 | Laboratoires Serobiologiques | Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen |
| US6358541B1 (en) | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
| JP3763567B2 (ja) * | 2001-01-19 | 2006-04-05 | 株式会社資生堂 | 化粧料 |
| DE60224838D1 (de) * | 2001-12-07 | 2008-03-13 | Regenesis Llc | Hydrophile polymere enthaltender reinigungsartikel |
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| GB0613333D0 (en) * | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| JP2008255020A (ja) * | 2007-04-02 | 2008-10-23 | Fujifilm Corp | 抗老化皮膚外用剤 |
| FR2991174B1 (fr) | 2012-06-01 | 2014-12-26 | Galderma Res & Dev | Composition dermatologique comprenant des oleosomes et des retinoides, son procede de preparation et son utilisation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3906108A (en) * | 1973-10-12 | 1975-09-16 | Johnson & Johnson | Stabilized tretinoin cream emulsion |
| US4247547A (en) * | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
| US4769013A (en) * | 1982-09-13 | 1988-09-06 | Hydromer, Inc. | Bio-effecting medical material and device |
| DE3612305A1 (de) * | 1986-04-11 | 1987-10-22 | Roehm Pharma Gmbh | Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere |
| US4971800A (en) * | 1988-07-08 | 1990-11-20 | The Regents Of The University Of California | Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents |
-
1992
- 1992-04-29 US US07/875,772 patent/US5650171A/en not_active Expired - Lifetime
-
1993
- 1993-04-20 EP EP93909329A patent/EP0670714B1/en not_active Expired - Lifetime
- 1993-04-20 ES ES93909329T patent/ES2127818T3/es not_active Expired - Lifetime
- 1993-04-20 DK DK93909329T patent/DK0670714T3/da active
- 1993-04-20 CA CA002134677A patent/CA2134677C/en not_active Expired - Fee Related
- 1993-04-20 JP JP5519294A patent/JPH07506109A/ja active Pending
- 1993-04-20 WO PCT/US1993/003540 patent/WO1993021904A1/en active IP Right Grant
- 1993-04-20 NZ NZ251858A patent/NZ251858A/en unknown
- 1993-04-20 AU AU39784/93A patent/AU679678B2/en not_active Ceased
- 1993-04-20 DE DE69322656T patent/DE69322656T2/de not_active Expired - Fee Related
- 1993-04-20 AT AT93909329T patent/ATE174505T1/de not_active IP Right Cessation
-
1996
- 1996-09-06 US US08/708,181 patent/US5700483A/en not_active Expired - Lifetime
-
1999
- 1999-03-12 GR GR990400769T patent/GR3029685T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE174505T1 (de) | 1999-01-15 |
| EP0670714A4 (en) | 1996-03-06 |
| ES2127818T3 (es) | 1999-05-01 |
| EP0670714A1 (en) | 1995-09-13 |
| DE69322656D1 (de) | 1999-01-28 |
| WO1993021904A1 (en) | 1993-11-11 |
| EP0670714B1 (en) | 1998-12-16 |
| CA2134677A1 (en) | 1993-11-11 |
| AU3978493A (en) | 1993-11-29 |
| AU679678B2 (en) | 1997-07-10 |
| CA2134677C (en) | 1998-12-15 |
| JPH07506109A (ja) | 1995-07-06 |
| US5700483A (en) | 1997-12-23 |
| DK0670714T3 (da) | 1999-08-23 |
| DE69322656T2 (de) | 1999-05-20 |
| US5650171A (en) | 1997-07-22 |
| NZ251858A (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3029685T3 (en) | Retinoic acid-containing compositions. | |
| US5091171B2 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use | |
| HU9203112D0 (en) | Medical preparative containing 4-biphenyl-acetic acid | |
| EP0297733A3 (en) | Pharmaceutical compositions comprising catecholic butanes | |
| AU3142195A (en) | Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation | |
| EP0355152A4 (en) | TOPICAL METRONIDAZOLE FORMULATIONS AND THE USE THEREOF AS MEDICINAL PRODUCTS. | |
| IL61967A (en) | Pharmaceutical compositions comprising antimicrobial azole derivatives,for the topical treatment of acne vulgaris | |
| ZA911728B (en) | Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors | |
| ITRM920761A1 (it) | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. | |
| AU1271592A (en) | Malic acid derivatives and compositions for the treatment of psoriasis | |
| HK1003028A1 (en) | Skin care composition | |
| GR3029536T3 (en) | Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses. | |
| ES451188A1 (es) | Un procedimiento para la preparacion de nuevas poliaminas. | |
| GB2163051A (en) | Medicinal composition for the treatment or prevention of acne by topical application | |
| IL112019A (en) | Pharmaceutical compositions for topical treatment of psoriasis | |
| MY110277A (en) | Acylsulfonamido-and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides, processes for their preparation and their use as medicaments | |
| DE3277898D1 (en) | Compositions for treating acne | |
| IT1288708B1 (it) | Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris. | |
| WO2001045664A3 (fr) | UTILISATION DE COMPOSES POLYCYCLIQUES AROMATIQUES EN TANT QU'ACTIVATEURS DES RECEPTEURS DE TYPE PPARs DANS UNE COMPOSITION COSMETIQUE OU PHARMACEUTIQUE | |
| ES2106689A1 (es) | Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea. | |
| GB2353214A (en) | Topical Composition | |
| TW259711B (en) | Pharmaceutical composition containing 4-biphenylacetic acid |